AbbVie
Giving over time
| Month | Given | Impact band | Activities logged |
|---|---|---|---|
| Dec 2025 | $0 | Not rated | 0 |
| Jan 2026 | $0 | Not rated | 0 |
| Feb 2026 | $0 | Not rated | 0 |
| Mar 2026 | $0 | Not rated | 0 |
| Apr 2026 | $0 | Not rated | 0 |
| May 2026 | $0 | Not rated | 0 |
| Jun 2026 | $0 | Not rated | 0 |
| Jul 2026 | $0 | Not rated | 0 |
| Aug 2026 | $0 | Not rated | 0 |
| Sep 2026 | $0 | Not rated | 0 |
| Oct 2026 | $0 | Not rated | 0 |
| Nov 2026 | $1,000,000 | Not rated | 1 |
Cause breakdown
About
AbbVie is a global biopharmaceutical company headquartered in North Chicago, Illinois, specializing in the discovery, development and delivery of advanced medicines. It became an independent company in January 2013 following its separation from Abbott Laboratories, building on a pharmaceutical heritage that spans more than a century. The company develops treatments for complex health conditions, including immunological disorders, cancer, neurological diseases, eye conditions and chronic illnesses. Its operations combine pharmaceutical research, biotechnology and commercial capabilities to bring new treatment options to patients and healthcare professionals worldwide. Beyond its pharmaceutical operations, AbbVie supports community development through its philanthropic arm, the AbbVie Foundation. Established in 2013, the foundation invests in initiatives designed to improve health equity, expand access to healthcare and address social barriers affecting underserved populations. Its activities include multi-year partnerships with nonprofit organizations, community health initiatives and employee volunteering programs. The foundation reports providing $389 million in grants to more than 310 organizations since 2013. Its investments support healthcare access, education, community resilience and innovative approaches to improving public health.
Activity feed
Board
Chairman since July 2025 and CEO since 2024; previously AbbVie's President and COO and its Chief Financial Officer. Joined Abbott in 1993 and AbbVie in 2013. Director since 2024.
President of Austin Investment Advisors. Former President and CEO of Move Networks and President and COO of DIRECTV; director of CrowdStrike, Freshworks and Verizon. AbbVie director since 2013.
Retired Senior Vice President and director at The Boston Consulting Group, where he was managing partner of the Los Angeles office from 1987 and an advisor from 2011 to 2023. AbbVie director since 2013.
Chief Executive Officer, Health Care at Procter & Gamble since 2022, with a 30+ year career at P&G; planned to retire from P&G in June 2026. AbbVie director since 2023.
Retired Chairman and CEO of Kimberly-Clark after 36 years at the company; Lead Independent Director at Lockheed Martin. AbbVie director since May 2025.
Retired Executive Vice President, Finance and Administration at Abbott Laboratories, where he was previously CFO. Director of Allergan from 2018 to 2020; AbbVie director since 2020.
President of United Airlines Holdings and United Airlines; previously its Chief Administrative Officer and General Counsel. AbbVie director since 2016.
Retired President of Chevron Asia Pacific Exploration and Production after a 37-year Chevron career; runs consulting firm Melody Meyer Energy, LLC. AbbVie director since 2017.
Irving S. Cutter Professor and Chair of Medicine at Northwestern University Feinberg School of Medicine; 2021–2022 President of the American Society of Nephrology. AbbVie director since 2023.
Retired Group President for Resource Industries at Caterpillar, where he was previously CFO; director of Xos, Inc. AbbVie director since 2013.
Retired President of Chevron Pipe Line Company after a 36-year Chevron career that began as a chemist and research scientist. AbbVie director since 2018.
Former Chairman and CEO of Northern Trust Corporation and The Northern Trust Company; director of IBM. AbbVie director since 2013.
Vice Chancellor for Health Sciences at UC San Diego. Appointed to AbbVie's board as a Class II director on October 14, 2026, and joined its Public Policy and Sustainability Committee.